在全球获取基因组疗法的公平性上进行导航,扩大对潜在变革性疗法的获取,并使需要的人受益,需要全球政策变化
Tsung-Ling Lee1, Tsutomu Sawai2,3,4
1Graduate Institute of Health and Biotechnology Law, Taipei Medical University, Taipei, Taiwan.
Frontiers in genetics
|April 19, 2024
概括
对状细胞疾病的第一个基因组疗法提供了希望,但高成本和基础设施问题造成了全球接入障碍. 需要进行政策改革,以确保患者平等获得这种开创性治疗.
科学领域:
- 遗传学 遗传学 是一个
- 血液学 血液学 血液学
- 公共卫生政策 公共卫生政策
背景情况:
- 状细胞病是一种使人虚弱的遗传性血液疾病,影响全球数百万人.
- 最近的监管批准标志着状细胞疾病遗传医学的一个重要里程碑.
- 现有的全球卫生结构对公平获得先进疗法提出了挑战.
研究的目的:
- 分析阻碍全球患者获得状细胞疾病新型基因组疗法的障碍.
- 提出政策改革,解决知情同意,治疗费用和监管监督问题.
- 在全球卫生公平与治理的更广泛背景下,对患者获取权的讨论进行框架.
主要方法:
- 审查监管批准和患者获取挑战.
- 分析影响医疗保健获取的社会经济和结构因素.
- 政策分析和建议制定,以提供公平的医疗保健服务.
主要成果:
- 针对状细胞疾病的第一个基因组疗法批准面临着重大进入障碍,包括成本,未成年人的同意,基础设施和监管差距.
- 这些障碍凸显了全球卫生治理中的结构性不平等.
- 现有的社会和制度安排显著影响患者获得先进的医疗治疗.
结论:
- 解决状细胞病的基因组治疗障碍需要采取全面的全球方法.
- 政策改革必须考虑知情同意,治疗负担能力和强大的监管框架.
- 实现健康公平需要致力于改革全球健康治理和研究优先事项.
更多相关视频
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
33.7K
07:49Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
157
相关概念视频
What is Genetic Engineering?
74.1K
Overview
74.1K
Issues And Trends In Healthcare Delivery System
5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K
Genomics
36.3K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
36.3K
Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
CRISPR
50.8K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.8K
Next-generation Sequencing
88.7K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
88.7K
